Jonathan Nunez

Dr. Jonathan Nunez is an Associate Professor in the Division of Infectious Diseases within the Department of Medicine at an academic medical institution. His work spans clinical practice, research, and education with a focus on addressing health disparities in addiction medicine and HIV care.

His educational background includes:

• Infectious Disease Fellowship, University of Pennsylvania Health System (Penn Medicine), completed in 2015
• Internal Medicine Residency, Yale-New Haven Medical Center, completed in 2011
• MD, University of Connecticut School of Medicine, completed in 2008

Dr. Nunez's research focuses on addiction medicine and health equity in medical education. Specifically, he has academic interests in improving access to medications for opioid use disorder (MOUD), HIV primary care and prevention services. His work contributes to UN Sustainable Development Goals related to health and education. His clinical interests include medical and resident education, HIV primary care and HIV prevention services.

His publication record shows significant research output from 2021-2025, with work spanning addiction medicine (particularly buprenorphine treatment protocols), HIV prevention (especially PrEP implementation), advanced diagnostic techniques for HIV, and high-impact meta-analyses on COVID-19 vaccine effectiveness. His research employs diverse methodologies including randomized clinical trials, systematic reviews, and novel diagnostic technology development.

Dr. Nunez has garnered significant scholarly attention, with his 2022 meta-analysis on COVID-19 vaccine effectiveness receiving 192 Scopus citations and being referenced in policy sources. His work has been widely disseminated through numerous news outlets and social media platforms, with some publications generating hundreds of mentions across Twitter and other channels.